Perspective Therapeutics (CATX) Tax Rate (2023)

Perspective Therapeutics (CATX) reported Tax Rate of 134.95% for Q4 2023, down 239.72% sequentially from 96.59% in Q1 2023.

Perspective Therapeutics (CATX) Tax Rate (2023) Analysis & Trends

Perspective Therapeutics (CATX) has 1 years of Tax Rate data on file, last reported at 134.95% in Q4 2023.

For the quarter ending Q4 2023, Tax Rate changed N/A year-over-year to 134.95%; the trailing twelve-month figure through Dec 2023 stood at 0.03% (changed N/A YoY), and the FY2023 full-year result was 0.02%, changed N/A from the prior year.
Tax Rate eased to 134.95% in Q4 2023, from 96.59% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 96.59% in Q1 2023 to a low of 134.95% in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	25.67%
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	12.35%
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	31.35%
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-15.15%
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	17.06%
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	25.97%
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-23.16%
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	18.61%
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Perspective Therapeutics	146.05 Mn	146.05 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	-134.95%
Dec 31, 2023	-134.95%
Dec 31, 2023	-134.95%
Mar 31, 2023	96.59%
Mar 31, 2023	96.59%
Mar 31, 2023	96.59%